Viamet Pharmaceuticals Corp (VMET) Financials

$10.34

$0.32 (3.19%)

As on 09-Sep-2026 16:00EDT

Market cap

$1,105 Mln

Revenue (TTM)

$73 Mln

P/E Ratio

28.2

P/B Ratio

2.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-13	Dec-12	Dec-11	Dec-10	Dec-09	Dec-08
Operating Revenue	73.25	34.76	12.03	3.14	--	2.87
Cost of Revenue	33.19	21.28	10.83	2.30	--	13.56
Gross Profit	40.06	13.48	1.19	0.84	--	--
Operating Expenses	11.50	7.64	16.36	5.74	--	--
Operating Profit (EBIT)	28.55	5.84	-4.33	-2.60	--	--
Other Income	--	--	--	--	--	--
Profit before Tax	52.29	29.60	-0.87	-2.50	--	--
Provision for Tax	15.57	9.27	--	--	--	--
Profit after Tax (Net Income)	36.72	20.33	-2.45	-3.12	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-13	Dec-12	Dec-11	Dec-10	Dec-09	Dec-08
Shareholder's Funds	394.08	233.96	211.33	113.77	63.74	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	340.68	151.17	2.07	27.49	6.53	--
Current Liabilities	52.51	32.88	16.85	16.48	8.94	2.29
Total Liabilities	839.77	418.01	230.25	157.74	79.21	2.72

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-13	Dec-12	Dec-11	Dec-10	Dec-09	Dec-08
Non-Current Assets	750.06	393.79	220.79	144.91	72.13	--
Current Assets	37.20	24.22	9.46	12.83	7.08	--
Total Assets	839.79	418.01	--	--	--	--
Total Debt*	374.55	141.00	--	--	--	--
Net Current Assets	-15.32	-8.66	-7.40	-3.65	-1.87	--

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-13	Dec-12	Dec-11	Dec-10	Dec-09	Dec-08
Cash From Operating Activities	--	16.95	7.40	0.62	--	--
Cash Flow from Investing Activities	--	-159.46	--	--	--	--
Cash from Financing Activities	--	144.84	-13.49	62.19	--	11.89
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-13	Dec-12	Dec-11	Dec-10	Dec-09	Dec-08
Adjusted EPS ($)	--	0.82	0.56	-0.03	--	--
Cash EPS ($)	--	--	0.73	-0.02	--	--
Adjusted Book Value ($)	--	--	6.43	2.28	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	0.47	0.08	--	--
Free Cash Flow per Share ($)	--	--	0.47	0.08	--	--

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-13	Dec-12	Dec-11	Dec-10	Dec-09	Dec-08
ROCE (%)	--	--	6.94	-1.51	-3.52	--
ROE (%)	--	11.69	9.13	-1.51	-3.52	--
ROA (%)	--	6.62	6.27	-1.26	-2.64	--
EBIT Margin (%)	--	71.08	120.15	--	--	--
Net Margin (%)	--	50.13	58.49	-20.36	-99.51	--
Cash Profit Margin (%)	--	0.00	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-13	Dec-12	Dec-11	Dec-10	Dec-09	Dec-08
Revenue Growth (%)	--	--	1.89	2.83	--	-0.18
EBIT Growth (%)	--	--	--	--	--	--
Net Profit Growth (%)	--	--	930.56	21.64	--	--
EPS Growth (%)	--	--	22.18	--	--	--
Book Value Growth (%)	--	-38.33	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-13	Dec-12	Dec-11	Dec-10	Dec-09	Dec-08
Price / Earnings	--	28.19	--	--	--	--
Price / Book Value	--	2.85	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	18.56	--	--	--	--
Close Price ($)	--	12.30	--	--	--	--
High Price ($)	--	15.00	--	--	--	--
Low Price ($)	--	9.10	--	--	--	--
Market Cap ($ Cr)	--	1,104.62	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-13	Dec-12	Dec-11	Dec-10	Dec-09	Dec-08
Debt to Equity	--	0.82	0.60	--	--	--
Short term debt to equity ratio	--	0.13	--	--	--	--
Current Ratio	--	0.71	0.74	0.56	0.78	--
Quick Ratio	--	0.71	--	--	--	--
Interest Coverage	--	4.83	3.43	--	--	--

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-13	Dec-12	Dec-11	Dec-10	Dec-09	Dec-08
Debtors to sales (%)	--	14.16	27.70	3.07	13.42	--
Asset Turnover	--	0.13	0.11	0.06	0.03	1.20
Receivable days	--	--	52.53	12.00	69.40	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	35.28	24.60	26.87	22.17
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.